Found 0 matching trials
Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell Lymphoma PHASE2 The objective of this study is to evaluate the efficacy and the safety of Z...
Show More Location
Groupe d'Etude des Lymphomes de l'adulte
Learn More & Join Trial
Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation PHASE2 The goal of this clinical research study is to learn if the addition of 90Y...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma PHASE2 Follicular lymphoma has historically been considered an incurable lymphoma....
Show More Location
Saint Louis University Cancer Center
Learn More & Join Trial
A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL) PHASE3 This is a Phase III, multicenter, open-label, randomized and controlled stu...
Show More Location
A.O.U. San Martino
Learn More & Join Trial
External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's Lymphoma PHASE1 The purpose of the research study is to learn whether external beam radiati...
Show More Learn More & Join Trial
Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma PHASE1 RATIONALE: Radiolabeled monoclonal antibodies such as yttrium Y90 ibritumom...
Show More Location
Hematology-Oncology Associates of Illinois
Learn More & Join Trial